Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Shikangte Pharmaceutical is a Chinese pharmaceutical company established in 1995 and headquartered in the Jiading District of Shanghai. The company specializes in the development, production, and sale of chemical drugs, with a particular focus on broad-spectrum antifungal treatments and generic formulations. Its product portfolio includes essential medications such as dexamethasone acetate and famotidine, for which it conducts bioequivalence studies to ensure quality and efficacy. Shikangte operates as a manufacturing-oriented enterprise, providing a range of therapeutic solutions for infections, inflammatory conditions, and gastrointestinal disorders. The company maintains GMP-compliant facilities to support its domestic commercial operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Shikangte Pharmaceutical.